Impact of the hypoxic phenotype on the uptake and efflux of nanoparticles by human breast cancer cells

Abstract Breast cancer cells adapt to the hypoxic tumoral environment by undergoing changes in metabolism, cell signalling, endo-lysosomal receptor uptake and recycling. The resulting hypoxic cell phenotype has the potential to undermine the therapeutic efficacy of nanomedicines designed for endocyt...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: William J. Brownlee, F. Philipp Seib
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9c9e13b623684df89ce2382f99d10d94
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9c9e13b623684df89ce2382f99d10d94
record_format dspace
spelling oai:doaj.org-article:9c9e13b623684df89ce2382f99d10d942021-12-02T11:41:14ZImpact of the hypoxic phenotype on the uptake and efflux of nanoparticles by human breast cancer cells10.1038/s41598-018-30517-32045-2322https://doaj.org/article/9c9e13b623684df89ce2382f99d10d942018-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-30517-3https://doaj.org/toc/2045-2322Abstract Breast cancer cells adapt to the hypoxic tumoral environment by undergoing changes in metabolism, cell signalling, endo-lysosomal receptor uptake and recycling. The resulting hypoxic cell phenotype has the potential to undermine the therapeutic efficacy of nanomedicines designed for endocytic uptake and specific intracellular trafficking. The aim of this study was to examine the impact of hypoxia and simulated reperfusion on the in vitro uptake and release of nanomedicines by human breast cancer cells. Cells were exposed to a hypoxic preconditioning treatment in 1% oxygen for 6 and 24 hours to induce temporal changes in the hypoxic circuit (e.g. HIF-1α expression). The preconditioned cells were then dosed with nanoparticles for 45 or 180 minutes emulating nanomedicine access following tumor reperfusion. Hypoxic preconditioning significantly increased nanoparticle retention by up to 10% when compared to normoxic cultures, with the greatest relative difference between normoxic and hypoxic cultures occurring with a 45 minute dosing interval. Exocytosis studies indicated that the preconditioned cells had a significantly increased nanoparticle efflux (up to 9%) when compared to normoxic cells. Overall, we were able to show that hypoxic preconditioning regulates both the endocytosis and exocytosis of nanomedicines in human breast cancer cells.William J. BrownleeF. Philipp SeibNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-11 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
William J. Brownlee
F. Philipp Seib
Impact of the hypoxic phenotype on the uptake and efflux of nanoparticles by human breast cancer cells
description Abstract Breast cancer cells adapt to the hypoxic tumoral environment by undergoing changes in metabolism, cell signalling, endo-lysosomal receptor uptake and recycling. The resulting hypoxic cell phenotype has the potential to undermine the therapeutic efficacy of nanomedicines designed for endocytic uptake and specific intracellular trafficking. The aim of this study was to examine the impact of hypoxia and simulated reperfusion on the in vitro uptake and release of nanomedicines by human breast cancer cells. Cells were exposed to a hypoxic preconditioning treatment in 1% oxygen for 6 and 24 hours to induce temporal changes in the hypoxic circuit (e.g. HIF-1α expression). The preconditioned cells were then dosed with nanoparticles for 45 or 180 minutes emulating nanomedicine access following tumor reperfusion. Hypoxic preconditioning significantly increased nanoparticle retention by up to 10% when compared to normoxic cultures, with the greatest relative difference between normoxic and hypoxic cultures occurring with a 45 minute dosing interval. Exocytosis studies indicated that the preconditioned cells had a significantly increased nanoparticle efflux (up to 9%) when compared to normoxic cells. Overall, we were able to show that hypoxic preconditioning regulates both the endocytosis and exocytosis of nanomedicines in human breast cancer cells.
format article
author William J. Brownlee
F. Philipp Seib
author_facet William J. Brownlee
F. Philipp Seib
author_sort William J. Brownlee
title Impact of the hypoxic phenotype on the uptake and efflux of nanoparticles by human breast cancer cells
title_short Impact of the hypoxic phenotype on the uptake and efflux of nanoparticles by human breast cancer cells
title_full Impact of the hypoxic phenotype on the uptake and efflux of nanoparticles by human breast cancer cells
title_fullStr Impact of the hypoxic phenotype on the uptake and efflux of nanoparticles by human breast cancer cells
title_full_unstemmed Impact of the hypoxic phenotype on the uptake and efflux of nanoparticles by human breast cancer cells
title_sort impact of the hypoxic phenotype on the uptake and efflux of nanoparticles by human breast cancer cells
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/9c9e13b623684df89ce2382f99d10d94
work_keys_str_mv AT williamjbrownlee impactofthehypoxicphenotypeontheuptakeandeffluxofnanoparticlesbyhumanbreastcancercells
AT fphilippseib impactofthehypoxicphenotypeontheuptakeandeffluxofnanoparticlesbyhumanbreastcancercells
_version_ 1718395415154393088